(Q45861101)

17 December 2017

title

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors (English)

1 reference

17 December 2017

1 reference

1 reference

Praus M

1

1 reference

17 December 2017

Wauterickx K

series ordinal

2

1 reference

17 December 2017

Collen D

series ordinal

3

1 reference

17 December 2017

Gerard RD

series ordinal

4

1 reference

17 December 2017

publication date

1 February 1999

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

227-236

1 reference

17 December 2017

Tumor invasion, proteolysis, and angiogenesis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Distribution of plasminogen activator inhibitor (PAI-1) in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Characterization of a newly derived human sarcoma cell line (HT-1080).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Significance of Vascular Endothelial Growth Factor/Vascular Permeability Factor for Solid Tumor Growth, and Its Inhibition by the Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Human 3 beta-hydroxysteroid dehydrogenase/delta 5----4isomerase from placenta: expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Why drinking green tea could prevent cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

7 January 2021

Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

7 January 2021

Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

7 January 2021

Reproductive organ blood flow measured using radioactive microspheres in diestrous and estrous mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300802

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3300802

1 reference

17 December 2017

Dimensions Publication ID

1040309949

0 references

1 reference

17 December 2017